Valuation: Monogram Technologies Inc.

Market Cap 244M 213M 198M 182M 342M 23.32B 351M 2.35B 919M 11.56B 915M 895M 39.84B P/E 2023
-5.61x
P/E 2024 -4.73x
Enterprise Value 228M 199M 186M 171M 321M 21.85B 328M 2.2B 861M 10.83B 858M 839M 37.34B EV / Sales 2023
257,522,925x
EV / Sales 2024 -
Free-Float
64.74%
Yield 2023 *
-
Yield 2024 -

Last Transcript: Monogram Technologies Inc.

1 year 5.23
Extreme 5.23
6.42
3 years 1.53
Extreme 1.53
6.42
5 years 1.53
Extreme 1.53
48.99
10 years 1.53
Extreme 1.53
48.99
Date Insider Type Main position Quantity % Market Cap.
7/10/25 Issuer sale

Director

7,000 0.0172%
7/10/25 Issuer sale

Director

40,000 0.0984%
7/10/25 Issuer sale

Chief Technology Officer

1,312,926 3.2312%
Change 5-day change 1-year change 3-year change Capi.($)
-1.80%-.--%+5.45%+29.03% 244M
+1.63%+11.97%-12.09%+24.47% 133B
+1.21%+8.00%+3.71%+2.19% 13.43B
+6.83%+5.60%+70.31%+111.74% 8.88B
-1.27%+4.27%-44.88%-69.82% 4.71B
+2.18%+0.25%+0.54%+38.53% 2.63B
+2.51%+11.66%+10.76%-52.17% 1.7B
+3.47%+1.44%-15.85%-23.38% 1.62B
+2.35%+3.25%-24.63%-33.29% 1.61B
Average +1.90%+2.79%-0.74%+3.03% 18.63B
Weighted average by Cap. +1.83%+4.98%-7.08%+23.10%

Financials

2023 2024
Net sales 0.36 0.32 0.3 0.27 0.51 34.91 0.52 3.52 1.38 17.3 1.37 1.34 59.65 -
Net income -13.75M -11.99M -11.19M -10.28M -19.3M -1.31B -19.76M -133M -51.82M -651M -51.6M -50.48M -2.25B -16.33M -14.24M -13.29M -12.21M -22.93M -1.56B -23.48M -157M -61.55M -774M -61.3M -59.97M -2.67B
Net Debt -13.1M -11.42M -10.66M -9.8M -18.39M -1.25B -18.83M -126M -49.37M -621M -49.17M -48.1M -2.14B -15.33M -13.36M -12.47M -11.47M -21.52M -1.47B -22.03M -148M -57.78M -726M -57.54M -56.29M -2.5B
Logo Monogram Technologies Inc.
Monogram Technologies Inc. is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining 3D printing, advanced machine vision, AI and robotics. The Company's mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its FDA-cleared mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. It is also exploring other clinical and commercial applications for mBos with mVision navigation. Its mVision technology leverages AI-trained algorithms to track pre-identified objects in real-time.
Employees
27
  1. Stock Market
  2. Stocks
  3. MGRM Stock